Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 ,inter alia, to consider and approve 1. To discuss, consider ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed the stock exchange that its Board of Directors will meet on Saturday, 08 November 2025. The main item on the agenda is to consider and approve the Unaudited Financial Results for the Quarter and Half Year ended 30 September 2025. The meeting may also take up any other matter with the Chair's permission. Additionally, the company's trading window has been closed since 01 October 2025 and will reopen 48 hours after the results are declared, in line with insider trading regulations.
No direct impact on the stock from this filing alone — it is a routine pre-results announcement. Investors should watch for the actual Q2 and H1 FY26 numbers on or after 08 November 2025, which could move the stock depending on how they compare with expectations.